The control of ornithinetranscarbamylase activity by arginase in Saccharomyces cerevisiae  by Messenguy, F. & Wiame, J.-M.
Volume 3, number 1 FEBS LETTERS April 1969 
THE CONTROL OF ORNITHINETRANSCARBAMYLASE ACTIVITY 
BY ARGINASE IN SACCHAROMYCES CEREVISIAE 
F. MESSENGUY and J.-M. WIAME 
Laboratoire de Microbiologic de Wniversid Libre de Bruxelles 
and Institut de Recherches du C.E.R.I.A., Bruxelles 7, Belgium 
Received 27 February 1969 
1. Introduction 
The synthesis of ornithinetranscarbamylase (OTC) 
in Saccharomyces cerevisiae is repressed by arginine 
and its activity is regulated by a mechanism which 
involves a regulatory binding protein induced by 
arginine [ 11. The regulatory mechanism was reconsti- 
tuted in vitro with partially purified OTC and regula- 
tory protein. This enabled us to show that ornithine 
in addition to being a substrate is also an effector of 
this system and that arginine which is an inducer of 
the regulatory protein becomes an inhibitor of OTC 
when the regulatory protein is present [2]. In the 
present paper, we wish to report conclusive experi- 
ments which show that the regulatory protein is an 
arginase which, when its substrate, arginine, and the 
product of its action, ornithine, are simultaneously 
present, binds OTC and inhibits its activity. This 
mechanism prevents the formation of a wasteful urea 
cycle. 
2. Material and methods 
Culture and purification methods and enzymatic 
assay are the classical ones [ 1,3,4]. The OTC activity 
@moles citrulline formed per hour) is measured at 
1.5’ for 5 min. Urea which interferes with citrulline 
determination is eliminated by urease (1 mg of Sigma 
type III, in 1 ml of incubation mixture). Arginase- 
less mutants are described elsewhere [6]. Arginase 
activity is given in moles of urea formed in 1 hr at 
30”. An arbitrary value of 100 units is given to the 
amount of regulatory activity found in 1 mg of total 
protein from wild-type strain 1705d grown on arginine 
as only nitrogen source. This preparation is used as a 
standard and inhibition of OTC is measured routinely 
in the presence of 10m3 M arginine and an excess of 
ornithine (1 Om2 M). The inhibition is a saturation-type 
function of the amount of regulatory protein and 
accurate determinations are done at less than 50% 
inhibition [3]. 
3. Results 
a. The regulation of OTC by a limited amount of 
regulatory protein and the actions of effecters are 
summarized in fig. 1. OTC is an enzyme which is in- 
hibited by an excess of ornithine. Arginine does not 
affect its activity. Addition of regulatory protein in- 
creases the inhibition by excess of substrate and this 
inhibition is strongly reinforced by arginine. 
b. A striking property of this regulatory process is 
that regulatory mutants (argR) simultaneously have 
lost most of the repressibility by arginine and the 
capacity to produce the regulatory protein [l] sug- 
gesting a link between this regulation and the 
anabolism. However, the role that ornithine appears 
to play in this regulation, focused attention on this 
intermediate which is known to be common to the 
anabolism and catabolism of arginine in a number of 
microbes, including yeast [7,4] . Moreover, an un- 
expected connection between the two metabolisms 
was disclosed by the discovery that the argR mutants 
were unable to grow on arginine or ornithine as nitro- 
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Fig. 1. Inhibition of OTC by the regulatory protein as a fine- 
tion of ornithine and arginine concentrations. The regulatory 
protein is a preparation from the mutant AG r deprived of 
arginase activity grown on glutamate + arginine (1 mg ml-l 
each): 62 units (0.6 mg per protein) per ml of a dialized pre- 
cipitate at 50% (NH&S04 saturation. Preparation from wild- 
type strains give similar results except that a small correction 
for ornithine concentration (< 0.5 X 10-s M) has to be made 
due to the formation of ornithine by arginase. 
11 
Bde Ldh’ Phc.2 
Arginase 
cyt.co 
ma Regulatory Protein0 UIW- 
3000 
2000 
0 
0 
loo0 ” 
,::, 
,’ ‘, 
4 
! 
f ., 
D 
0 
,* *' 
0 20 30 
“FRACTION?‘Nr 
Fig. 2a. Arginase and the regulatory protein have the same 
molecular weight. Arginase and regulatory activities in frac- 
tions from an elution on Sephadex G200 superfine (Pharma- 
cia) [S] of 28,000 units of regulatory protein (purified 150 
fold) by Tris 0.05 M pH 8, KC1 0.2 M, arginine 1O-3 M. 
Bd (-o-): blue dextran (Pharmacia). Phos (-+-): E. coli 
alcaline phosphatase (Worthington Biochem. Corp.) M.W. 
75,000. Ldh (-•-): rabbit muscle lactic dehydrogenase 
(Boehringer) M.W. 135,000. Cyt-C (a): cytochrome C 
(Boehringer) M.W. 12,400. 
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Fig. 2b. Binding of OTC and arginase. A mixture of arginase 
(7000 units, purified 150 fold) and OTC (4800 units) eluted 
as in fig. 2a except: addition of ornithine 1.5 X 10-a M. 
Fig. 2c. Arginase and OTC do not bind in the absence of 
effecters. Same conditions as for fig. 2b except: no ornithine 
and no arginine. 
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gen source because of a pleiotropic non inducibility 
of arginase and SLornithine transaminase [6]. As 
appears in fig. 2a, the molecular weights of the mate- 
rials bearing the regulatory- and the arginase activities 
are similar (114,000 5 7,000). The molecular weight 
of OTC is slightly higher (fig. 2~). It was also observed 
that the purification of the arginase- and of the regula- 
tory activities are strikingly parallel, one step among 
others, being a thermodenaturation at 63” for 20 min 
in the presence of 0.1 M Larginine [3]. 
c. A mutant AGI deficient in arginase activity [6] 
(less than 1% of normal activity) retains a full regu- 
latory activity (fig. l), while two other mutants, AG2 
and AG3, have lost both catalytic and regulatory ac- 
tivities. 
Together these results are much in favour of the 
identity of arginase and the regulatory protein; the 
AG1 strain produces a regulatory protein which has 
lost its arginase activity. 
The experiments reported in figs. 2a-c give a direct 
demonstration of the binding of arginase with OTC. 
When an excess of regulatory protein from a wild- 
type strain is sifted in the presence of OTC, orni- 
thine and arginine, all OTC and a part of arginase 
activity move together with an apparent molecular 
weight of 180,000 f 20,000. The unbound arginase 
remains at a M.W. of 114,000 (fig. 2b). In the absence 
of effecters, OTC and arginase move to their usual 
elution volume (fig. 2~). These data confirm the bind- 
ing and the stoichiometric character of this interac- 
tion [ 11. They also exclude the possibility that in the 
AG2 and AG, strains, a mutation in the gene coding 
for arginase would, through a polar effect, affect the 
production of a distinct regulatory protein coded by 
an adjacent gene. 
Fig. 3. Simplified scheme of arginine biosynthesis (=S*), 
catabolism (*e) and action of effecters (- - - -) which 
contribute to OTC inhibition. 
The comparison of OTC and arginase of other 
microbes including many yeasts [2,3], shows that 
this regulation is very general in the genus Succharo- 
myces and not common in the other ones. Cross reac- 
tions show that the specificity is brought by both 
arginase [3] and OTC [2]. The property of OTC to 
be inhibited by excess of ornithine seems to be re- 
quired for this regulation. 
d. The physiological result of this regulation is the 
prevention of the occurrence of a wasteful urea cycle 
(4 ATP) which could operate when arginine or orni- 
thine (which is also an inducer of arginase [4,6] are 
catabolized (fig. 3). It should be emphasized that 
this control is active only when the catabolic pathway 
is at work and combines the economy of protein syn- 
thesis by a genotropic control with the rapidity of 
enzymotropic control. 
The term “epiprotein” has been used to designate 
the regulatory protein [2]. It is useful to distinguish 
a regulatory arginase forming an allosteric system by 
reversible binding with OTC [ 81 from usual arginase 
by the name “epiarginase”. 
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